Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Fulgent Genetics Inc (NQ: FLGT ) 22.02 UNCHANGED Streaming Delayed Price Updated: 10:21 AM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 13,555 Open 22.13 Bid (Size) 21.97 (1) Ask (Size) 22.06 (4) Prev. Close 22.02 Today's Range 21.74 - 22.54 52wk Range 18.91 - 44.09 Shares Outstanding 29,926,846 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024 July 11, 2024 From Fulgent Genetics, Inc. Via Business Wire Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer June 03, 2024 From Fulgent Pharma Via Business Wire Performance YTD -24.82% -24.82% 1 Month +11.32% +11.32% 3 Month +9.50% +9.50% 6 Month -15.70% -15.70% 1 Year -46.04% -46.04% More News Read More Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting May 24, 2024 From Fulgent Pharma Via Business Wire Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics May 14, 2024 From Fulgent Pharma Via Business Wire Earnings Preview: Fulgent Genetics November 02, 2023 Via Benzinga FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024 May 03, 2024 Via InvestorPlace Fulgent Reports First Quarter 2024 Financial Results May 03, 2024 From Fulgent Genetics, Inc. Via Business Wire Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024 April 11, 2024 From Fulgent Genetics, Inc. Via Business Wire Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results February 28, 2024 From Fulgent Genetics, Inc. Via Business Wire Why Is Fulgent Genetics Stock Moving Higher Today? August 04, 2023 Via Benzinga Earnings Outlook For Fulgent Genetics August 03, 2023 Via Benzinga Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024 February 13, 2024 From Fulgent Genetics, Inc. Via Business Wire The 3 Best Digital Health Stocks for Personalized Medicine November 25, 2023 Via InvestorPlace Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference November 14, 2023 From Fulgent Genetics, Inc. Via Business Wire Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting November 03, 2023 From Fulgent Genetics, Inc. Via Business Wire Earnings Scheduled For November 3, 2023 November 03, 2023 Via Benzinga Fulgent Reports Third Quarter 2023 Financial Results November 03, 2023 From Fulgent Genetics, Inc. Via Business Wire Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting October 25, 2023 From Fulgent Genetics, Inc. Via Business Wire Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023 October 17, 2023 From Fulgent Genetics, Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session September 29, 2023 Via Benzinga Fulgent Reports Second Quarter 2023 Financial Results August 04, 2023 From Fulgent Genetics, Inc. Via Business Wire Earnings Scheduled For August 4, 2023 August 04, 2023 Via Benzinga Exagen Inc. Appoints Paul Kim to Board of Directors July 24, 2023 From Exagen Inc. Via GlobeNewswire Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023 July 18, 2023 From Fulgent Genetics, Inc. Via Business Wire Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist June 06, 2023 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
